NKGen Biotech Operating Income

NKGen Biotech (NKGN) currently reports a operating income of $-24M as of March 2025. That compares with $-27M in the prior-year period — up 9.8% year over year. Use the charts on this page to explore NKGen Biotech's operating income history and peer comparisons.

NKGen Biotech's operating income increased from $-27M to $-24M — a 9.8% year-over-year increase (period ending March 2025). Watching multi-year history on the chart below helps separate one-off swings from a lasting trend.

NKGen Biotech reported $-24M in operating income as of March 2025. That compares with $-27M in the prior-year period — up 9.8% year over year. Absolute dollar amounts are most useful when compared with prior periods, peers, and related line items such as revenue, assets, or liabilities on Stockcircle.

Start with the current operating income of $-24M, then check the historical chart for trend and the peer comparison chart for relative positioning. From there, open related valuation or income-statement pages for NKGen Biotech, and consider following NKGN for alerts when major investors trade the stock.